As of 3:59pm ET
| -0.11 / -6.29%|
The 3 analysts offering 12-month price forecasts for Intellipharmaceutics International Inc have a median target of 8.00, with a high estimate of 12.00 and a low estimate of 6.00. The median estimate represents a +387.80% increase from the last price of 1.64.
The current consensus among 3 polled investment analysts is to Buy stock in Intellipharmaceutics International Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.